Assembly Biosciences (ASMB) Change in Accured Expenses (2010 - 2026)

Assembly Biosciences' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$849000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 81.38% year-over-year to -$849000.0; the TTM figure through Mar 2026 stood at $3.8 million (up 1423.9% YoY), while the FY2025 annual figure was $114000.0, down 89.8% from the prior year.
• Change in Accured Expenses was -$849000.0 for Q1 2026 at Assembly Biosciences, down from -$671000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $5.4 million in Q2 2022 to a low of -$4.6 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged -$86235.3 across 5 years, with a median of -$68000.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses surged 3183.82% in 2024, then tumbled 132.0% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $904000.0 in 2022, then plunged by 107.52% to -$68000.0 in 2023, then surged by 3183.82% to $2.1 million in 2024, then tumbled by 132.0% to -$671000.0 in 2025, then declined by 26.53% to -$849000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$849000.0 (Q1 2026), -$671000.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.